Erosive nappy erythema following sunitinib intake
Saoussane Kharmoum, Hassan Errihani
The Pan African Medical Journal. 2013;14:46. doi:10.11604/pamj.2013.14.46.2235

Innovations in Measles Elimination Innovations in Measles Elimination
"Better health through knowledge sharing and information dissemination "

Images in medicine

Erosive nappy erythema following sunitinib intake

Cite this: The Pan African Medical Journal. 2013;14:46. doi:10.11604/pamj.2013.14.46.2235

Received: 26/11/2012 - Accepted: 29/11/2012 - Published: 01/02/2013

Key words: Erosive, erythema, sunitinib, antiangiogenic drug

© Saoussane Kharmoum et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Available online at: http://www.panafrican-med-journal.com/content/article/14/46/full

Corresponding author: Saoussane Kharmoum MD, Department of medical oncology, National institute of oncology, Rabat Morocco (saoussane.oncomed@gmail.com)


Erosive nappy erythema following sunitinib intake

 

Saoussane Kharmoum1,&, Hassan Errihani1

 

1Department of medical oncology, National institute of oncology, Rabat Morocco

 

 

&Corresponding author
Saoussane Kharmoum MD, Department of medical oncology, National institute of oncology, Rabat Morocco

 

 

Image in medicine

We report on the case of a 54 years old man treating for a metastatic renal carcinoma who had experienced a dermatological toxicity referring to sunitinb intake. The antiangiogenic drug was delivered at a daily dose of 50mg for 4 weeks followed by two weeks of rest. By the second week of treatment the patient presented a nappy erythema evolving towards erosive lesions bleeding at mild friction and extending to the perianal and scrotal area, the process fulfilled the maximal intensity at 4 weeks and improved after the discontinuation of sunitinib. The patient refused the reintroduction of the drug. No skin biopsy was developed seeing that the lesions disappeared 4 weeks later.

Figure 1: Erosive nappy erythema (A) and scrotal erythema (B)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


The Pan African Medical Journal articles are archived on Pubmed Central. Access PAMJ archives on PMC here

Volume 33 (May - August 2019)

Article tools

PDF (237 Kb)
Contact the corresponding author
Download to Citation Manager
EndNote
Reference Manager
Zotero
BibTex
ProCite


This article authors

On Pubmed
On Google Scholar

Navigate this article

Keywords

Erosive
Erythema
Sunitinib
Antiangiogenic drug

Rate this article

Altmetric

PAMJ is a member of the Committee on Publication Ethics
PAMJ Authors services
Next abstract

PAMJ is published in collaboration with the African Field Epidemiology Network (AFENET)
Currently tracked by: DOAJ, AIM, Google Scholar, AJOL, EBSCO, Scopus, Embase, IC, HINARI, Global Health, PubMed Central, PubMed/Medline, Ulrichsweb, More to come . Member of COPE.

ISSN: 1937-8688. © 2019 - Pan African Medical Journal. All rights reserved